From microbiome science to innovative health solutions: Zinereo Pharma strengthens its presence at Vitafoods Asia 2026

From 2–4 September, Zinereo Pharma returned to Vitafoods Asia in Bangkok for the second consecutive year, reinforcing its presence in one of the key international meeting points for the nutraceutical industry in the Asia-Pacific region.

The event provided an opportunity to connect with current and potential partners, exchange perspectives on emerging market needs and showcase how Zinereo Pharma is translating microbiome science into differentiated, evidence-based health solutions.

One microbiome, multiple connections to health

• At Vitafoods Asia 2026, Zinereo Pharma presented its portfolio through three key microbiome axes, reflecting the growing scientific understanding of the connections between the gut microbiome and different areas of human health.
• The Gut–Respiratory Axis featured Pharmalactis Breathe® and Otibiome, both selected for the Vitafoods Asia New Product/Ingredient Zone, where some of the latest product and ingredient innovations in the industry were showcased.
• The Gut–Women’s Health & Fertility Axis highlighted Zinereo Pharma’s expertise in women’s health, urogenital microbiota and fertility through Giniwa® and Fertibiome®.
• The Gut–Immune Axis focused on the connection between gut microbiota, digestive health and immune function, featuring Flowbiotic® and Nutralactis®.

Different health needs, interconnected through the microbiome

This integrated approach is at the heart of Zinereo Pharma’s strategy: combining selected probiotic strains, scientific evidence and targeted formulations to develop solutions addressing specific health needs across different stages of life.

Strengthening international partnerships

Beyond showcasing our portfolio, Vitafoods Asia was an important opportunity to strengthen existing relationships and explore new collaborations and business opportunities across Asia-Pacific and other international markets.

We would like to thank all the clients, partners and industry professionals who visited us and contributed to three days of valuable scientific and business conversations.

We look forward to continuing to turn microbiome science into meaningful health solutions, growing together with our partners worldwide.